Chen Daniel ShinYu's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Jul 6, 2021
- Accession no.
- 0001209191-21-045686
- Filed
- Jul 6, 2021
- Trade date
- Jul 1-6, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $78.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chen Daniel ShinYuCIK 0001787681 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +1,900 | $1.39 | +$2,641 | 118,418 | Direct | |
| Jul 1, 2021 | Common Stock | FTax withholdingDisposed | −957 | $89.43 | −$85,584.51 | 117,461 | Direct | |
| Jul 6, 2021 | Common Stock | SSaleDisposed | −943 | $82.75 | −$78,033.25 | 116,518 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −1,900 | $0.00 | $0 | 338,340 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.